Postpartum peripheral nerve issues are an unusual obstetrical complication, with most instances ensuing from intrinsic obstetric palsies. We current the case of a full-term nulliparous pregnant 33-year-old girl with a vacuum-assisted vaginal supply as a result of a protracted second stage of labour and occipitoposterior place of the fetal head. For analgesia, a mixed spinal-epidural approach was used. 4 hours after supply, the affected person skilled a painless uneven motor deficit and hypoesthesia within the decrease limbs, adopted by sphincter disturbance. Emergent MRI was unremarkable. Electromyography confirmed indicators of a bilateral lumbosacral radiculopathy. The affected person skilled a gradual restoration over the next 2 months.
Though a definitive aetiological prognosis couldn’t be confirmed, a lumbosacral polyradiculopathy as a result of intrinsic obstetric complication was thought of. The affected person offered a number of danger components identified to be related to intrinsic obstetric palsies. Obstetricians and anaesthesiologists have an necessary function in stopping and diagnosing postpartum peripheral nerve disorderswe current a case of CIDP with hypertrophic nerves and evaluate it to earlier studies. The principle scientific findings had been insidious onset, gait ataxia and sensory signs. Electrodiagnostic research confirmed very sluggish nerve conduction velocities, a number of conduction blocks, distal CMAP length improve and absence of F-waves.
The protein degree within the cerebrospinal fluid was very excessive. Nerve ultrasound confirmed swelling of all peripheral nerves outdoors entrapment websites, with vital variability inside totally different segments of the identical nerve; nerves had been massively enlarged (as much as 10-fold regular values). Mind MRI confirmed hypertrophic cranial nerves, with gadolinium-enhancement. Spinal MRI confirmed hypertrophy of spinal roots and cauda equine, with gadolinium enhancement. Genetic take a look at (PMP22 duplication/deletion, Complete Exome Sequencing panel for neuropathies) resulted detrimental.
The affected person had a relapsing-remitting course and responded to immunoglobulin remedy. Spinal twine compression secondary to nerve root hypertrophy is commonly attributed to hereditary neuropathies. Nevertheless, to keep away from misdiagnosis, uncommon immune-mediated neuropathy reminiscent of persistent inflammatory demyelinating polyradiculoneuropathy (CIDP) shouldn’t be neglected. This report presents a case of multilevel nerve root hypertrophy resulting in vital twine compression from CIDP. Within the current report, the authors display {that a} myxopapillary ependymoma might current as an remoted gluteal mass hooked up to the coccygeal nerve, with out frank CNS involvement.
Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
Neuronal aggregates of misfolded alpha-synuclein protein are discovered within the mind and periphery of sufferers with Parkinson’s illness. Braak and colleagues have hypothesized that the preliminary formation of misfolded alpha-synuclein might begin within the intestine, after which unfold to the mind by way of peripheral autonomic nerves hereby affecting a number of organs, together with the guts and gut. Age is taken into account the best danger issue for Parkinson’s illness, however the impact of age on the formation of pathology and its propagation has not been studied intimately.
We aimed to research whether or not propagation of alpha-synuclein pathology from the intestine to the mind is extra environment friendly in outdated versus younger wild-type rats, upon gastrointestinal injection of aggregated alpha-synuclein. Our outcomes display a sturdy age-dependent gut-to-brain and brain-to-gut unfold of alpha-synuclein pathology alongside the sympathetic and parasympathetic nerves, leading to age-dependent dysfunction of the guts and abdomen, as noticed in sufferers with Parkinson’s illness.
Furthermore, alpha-synuclein pathology is extra densely packed and immune to enzymatic digestion in outdated rats, indicating an age-dependent maturation of alpha-synuclein aggregates. Our research is the primary to supply an in depth investigation of alpha-synuclein pathology in a number of organs inside one animal mannequin, together with the mind, pores and skin, coronary heart, gut, spinal twine and autonomic ganglia. Taken collectively, our findings counsel that age is an important issue for alpha-synuclein aggregation and full propagation to coronary heart, abdomen and pores and skin, much like sufferers.
On condition that age is the best danger issue for human Parkinson’s illness, it appears probably that older experimental animals will yield probably the most related and dependable findings. These outcomes have necessary implications for future analysis to optimize diagnostics and therapeutics in Parkinson’s illness and different age-associated synucleinopathies. Elevated emphasis ought to be positioned on utilizing aged animals in preclinical research and to elucidate the character of age-dependent interactions. Moreover, an interdisciplinary method to surgical resection of this lesion seems to symbolize an efficient remedy modality.
Surgical administration of a uncommon myxopapillary ependymoma of the gluteal area: A case report
Ependymomas are uncommon tumors originating from neuroepithelial cells lining the wall of the ventricles or central canal of the spinal twine. Whereas these tumors primarily happen inside the central nervous system (CNS), there are occasional studies in kids and younger grownup sufferers with a main tumor incidence outdoors of the CNS. Ependymomas of the sacrococcygeal area have been occasionally described within the literature with no normal of care established. We current a case report and evaluate of the literature concerning this uncommon entity.
 Antibody) Nerve Growth Factor (NGF) Antibody |
|
abx033672-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Nerve Growth Factor (NGF) Antibody |
|
abx033672-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx214597 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx214598 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177728 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177729 |
Abbexa |
-
EUR 398.00
-
EUR 133.00
-
EUR 1066.00
-
EUR 523.00
-
EUR 300.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177730 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177731 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177732 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177733 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177734 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177735 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173733 |
Abbexa |
-
EUR 300.00
-
EUR 718.00
-
EUR 384.00
-
EUR 154.00
-
EUR 244.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173734 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173735 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173736 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173737 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173738 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173739 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx301783 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx328869 |
Abbexa |
|
|
|
|
) beta nerve growth factor Antibody (Biotin) |
|
20-abx106104 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) beta nerve growth factor Antibody (FITC) |
|
20-abx107518 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx125372 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx126252 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx126983 |
Abbexa |
|
|
|
|
) beta nerve growth factor Antibody (HRP) |
|
20-abx108937 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) beta Nerve Growth Factor (Ngf) Antibody |
|
20-abx110383 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Beta-Nerve Growth Factor (Ngf) Antibody |
|
20-abx114048 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx114049 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx318150 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Nerve Growth Factor (NGF) Antibody (HRP) |
|
20-abx319462 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Nerve Growth Factor (NGF) Antibody (FITC) |
|
20-abx319463 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx319464 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (HRP) |
|
20-abx314512 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (FITC) |
|
20-abx314513 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx314514 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody Pair) Nerve Growth Factor (NGF) Antibody Pair |
|
20-abx370100 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Nerve Growth Factor (NGF) Antibody Pair |
|
20-abx370140 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx001709 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx037622-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx011244-100ul |
Abbexa |
100 ul |
EUR 411 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx433034-200ul |
Abbexa |
200 ul |
EUR 384 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx241119 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx214766 |
Abbexa |
|
|
|
|
 Antibody) Nerve Growth Factor IB (NGFIB) Antibody |
|
20-abx177736 |
Abbexa |
-
EUR 453.00
-
EUR 133.00
-
EUR 1302.00
-
EUR 620.00
-
EUR 342.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor IB (NGFIB) Antibody |
|
20-abx173740 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx271922 |
Abbexa |
-
EUR 398.00
-
EUR 230.00
-
EUR 1080.00
-
EUR 537.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx332306-100ul |
Abbexa |
100 ul |
EUR 425 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx327262 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx328143 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
P1020-01m |
SAB |
0.1m |
EUR 260 |
Nerve Growth Factor Receptor (NGFR) Antibody |
|
P1020-1ml |
SAB |
1ml |
EUR 999 |
) Recombinant Nerve Growth Factor (NGF) |
|
4-RPA105Eq01 |
Cloud-Clone |
-
EUR 471.84
-
EUR 229.00
-
EUR 1494.40
-
EUR 564.80
-
EUR 1029.60
-
EUR 379.00
-
EUR 3586.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Horse Nerve Growth Factor expressed in: E.coli |
Recombinant Nerve Growth Factor (NGF) |
|
4-RPA105Hu01 |
Cloud-Clone |
-
EUR 350.88
-
EUR 197.00
-
EUR 1040.80
-
EUR 413.60
-
EUR 727.20
-
EUR 298.00
-
EUR 2452.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Nerve Growth Factor expressed in: E.coli |
Recombinant Nerve Growth Factor (NGF) |
|
4-RPA105Ra01 |
Cloud-Clone |
-
EUR 503.20
-
EUR 238.00
-
EUR 1612.00
-
EUR 604.00
-
EUR 1108.00
-
EUR 400.00
-
EUR 3880.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Nerve Growth Factor expressed in: E.coli |
) Active Nerve Growth Factor (NGF) |
|
4-APA105Hu01 |
Cloud-Clone |
-
EUR 637.60
-
EUR 274.00
-
EUR 2116.00
-
EUR 772.00
-
EUR 1444.00
-
EUR 490.00
-
EUR 5140.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Nerve Growth Factor expressed in: E.coli |
Active Nerve Growth Factor (NGF) |
|
4-APA105Ra01 |
Cloud-Clone |
-
EUR 673.44
-
EUR 283.00
-
EUR 2250.40
-
EUR 816.80
-
EUR 1533.60
-
EUR 514.00
-
EUR 5476.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Nerve Growth Factor expressed in: E.coli |
) Eukaryotic Nerve Growth Factor (NGF) |
|
4-EPA105Hu61 |
Cloud-Clone |
-
EUR 476.32
-
EUR 230.00
-
EUR 1511.20
-
EUR 570.40
-
EUR 1040.80
-
EUR 382.00
-
EUR 3628.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Nerve Growth Factor expressed in: 293F Cell |
 Mouse beta Nerve Growth Factor |
|
7-00205 |
CHI Scientific |
5µg |
Ask for price |
Mouse beta Nerve Growth Factor |
|
7-00206 |
CHI Scientific |
20µg |
Ask for price |
Mouse beta Nerve Growth Factor |
|
7-00207 |
CHI Scientific |
1mg |
Ask for price |
 beta Nerve Growth Factor Protein |
|
20-abx260001 |
Abbexa |
-
EUR 1358.00
-
EUR 230.00
-
EUR 217.00
|
|
|
|
beta Nerve Growth Factor Protein |
|
20-abx261663 |
Abbexa |
-
EUR 3418.00
-
EUR 328.00
-
EUR 230.00
|
|
|
|
 beta Nerve Growth Factor Peptide |
|
20-abx262393 |
Abbexa |
-
EUR 6397.00
-
EUR 328.00
-
EUR 230.00
|
|
|
|
 Pro-Nerve Growth Factor Protein |
|
20-abx263136 |
Abbexa |
-
EUR 1372.00
-
EUR 328.00
-
EUR 230.00
|
|
|
|
 Monoclonal Antibody (Human)) Nerve Growth Factor (NGF) Monoclonal Antibody (Human) |
|
4-MAA105Hu21 |
Cloud-Clone |
-
EUR 228.00
-
EUR 2219.00
-
EUR 559.00
-
EUR 283.00
-
EUR 206.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Nerve Growth Factor (NGF) |
 Polyclonal Antibody (Human)) Nerve Growth Factor (NGF) Polyclonal Antibody (Human) |
|
4-PAA105Hu01 |
Cloud-Clone |
-
EUR 217.00
-
EUR 2048.00
-
EUR 520.00
-
EUR 268.00
-
EUR 201.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Nerve Growth Factor (NGF) |
Nerve Growth Factor (NGF) Polyclonal Antibody (Human) |
|
4-PAA105Hu06 |
Cloud-Clone |
-
EUR 229.00
-
EUR 2232.00
-
EUR 562.00
-
EUR 284.00
-
EUR 206.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Nerve Growth Factor (NGF) |
(NGFR5) Antibody) NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC040890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405S conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC040890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405S conjugate, Concentration: 0.1mg/mL |
 Antibody (HRP)) Nerve Growth Factor Receptor (NGFR) Antibody (HRP) |
|
20-abx316117 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Nerve Growth Factor Receptor (NGFR) Antibody (FITC) |
|
20-abx316118 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Nerve Growth Factor Receptor (NGFR) Antibody (Biotin) |
|
20-abx316119 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx103386 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC470890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF647 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC470890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF647 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCAP0890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCAP0890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCB0890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCB0890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC810890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC810890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680R conjugate, Concentration: 0.1mg/mL |
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx132002 |
Abbexa |
-
EUR 328.00
-
EUR 815.00
-
EUR 425.00
-
EUR 154.00
-
EUR 258.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Beta-Nerve Growth Factor (NGF beta) Antibody |
|
20-abx133543 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC700890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC700890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC880890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC880890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC610890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC610890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC680890-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC680890-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCA0890-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), APC conjugate, Concentration: 0.1mg/mL |
A 24-year-old girl offered with proper gluteal ache worsened by sitting and a palpable delicate tissue mass of the sacrococcygeal area. Magnetic resonance imaging revealed a 3.7 cm cystic mass centered in the correct gluteal area. She underwent a biopsy at an out of doors establishment, with histology revealing myxopapillary ependymoma. The affected person was referred to our hospital and underwent an interdisciplinary neurosurgical and orthopedic oncology en bloc resection of the ependymoma, which intraoperatively appeared to originate from the coccygeal nerve.
